share_log

8-K: Current report

SEC ·  Jun 1 05:05
Summary by Futu AI
On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.
On May 28, 2024, Conduit Pharmaceuticals Inc. received a notice from The Nasdaq Stock Market LLC indicating that the company is not in compliance with Nasdaq's independent audit committee requirements. This non-compliance occurred following the resignation of Ms. Jennifer McNealey from the Board and all committees, leaving the audit committee with only two independent directors. The company has been given until the earlier of its next annual shareholders' meeting or May 13, 2025, to regain compliance, with an extended deadline of November 12, 2024, if the annual meeting occurs before that date. The notice does not affect the current listing of the company's securities on Nasdaq. Conduit Pharmaceuticals plans to address the issue by appointing at least one more independent director to the audit committee within the given timeframe.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.